Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsStem CellsMyeloablative AgonistsScleroderma, SystemicBusulfanGraft vs Host DiseaseHematopoietic Stem CellsTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineCord Blood Stem Cell TransplantationHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateWhole-Body IrradiationTime FactorsSurvival AnalysisInfectionLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountImmunosuppressive AgentsHistocompatibility TestingPrednisoneCarboplatinLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineMultiple SclerosisRecombinant ProteinsFollow-Up StudiesBlood Cell CountLeukemiaAntineoplastic AgentsProspective StudiesBone Marrow PurgingEmbryonic Stem CellsBlood CellsLymphomaCytomegalovirus InfectionsFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesAdult Stem CellsScleroderma, DiffuseMesenchymal Stem Cell TransplantationImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousT-LymphocytesLymphocyte DepletionLiver TransplantationLeukocytes, MononuclearBone MarrowCells, CulturedCell SeparationHLA AntigensScleroderma, LimitedFlow CytometryPrognosisHematologic Diseases